CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
-2.85%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.76B
AUM Growth
+$46.6M
(+2.7%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
5.87%
Top 10 Holdings %
Top 10 Hldgs %
56.83%
Holding
37
New
8
Increased
10
Reduced
6
Closed
4
Top Buys
| 1 |
Biogen
BIIB
|
$81.5M |
| 2 |
Alkermes
ALKS
|
$64.6M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$44.1M |
| 4 |
AbbVie
ABBV
|
$37.9M |
| 5 |
Novo Nordisk
NVO
|
$36.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$67.6M |
| 2 |
MDCO
Medicines Co
MDCO
|
$62M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$60M |
| 4 |
AGN
Allergan plc
AGN
|
$42.1M |
| 5 |
DaVita
DVA
|
$28.5M |
Sector Composition
| 1 | Healthcare | 97.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GSK
GSK
$81.5B
| $21.3M | 1.12% |
400,000
| – | – |
|
|
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
| $15.5M | 0.81% |
+750,000
| New | +$15.5M |
|
|
CBIO
28
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $15.1M | 0.79% |
+35,000
| New | +$15.1M |
|
|
TBIO
29
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $14.9M | 0.78% |
+1,500,000
| New | +$14.9M |
|
|
TECX
30
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $7.06M | 0.37% |
+41,667
| New | +$7.06M |
|
31
Sutro Biopharma
STRO
$89.9M
| $5.45M | 0.29% |
600,000
| – | – |
|
32
Surgery Partners
SGRY
$2.89B
| $1.18M | 0.06% |
160,084
| – | – |
|
|
33
Gilead Sciences
GILD
$143B
| – | – |
-1,000,000
| Closed | -$67.6M |
|
34
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
|
35
Teva Pharmaceuticals
TEVA
$21.7B
| – | – |
-6,500,000
| Closed | -$60M |
|
36
TG Therapeutics
TGTX
$5.11B
| – | – |
-1,000,000
| Closed | -$8.65M |
|
|
MDCO
37
DELISTED
Medicines Co
MDCO
| – | – |
-1,700,000
| Closed | -$62M |
|